Genetically engineered immune cells show promise for fighting relapsed blood cancer
Researchers are presenting preliminary results from a clinical study of an investigational cellular immunotherapy for Hodgkin lymphoma and non-Hodgkin lymphoma expressing the CD30 protein marker.
from Latest Science News -- ScienceDaily https://ift.tt/2RxWVXo
from Latest Science News -- ScienceDaily https://ift.tt/2RxWVXo
Comments
Post a Comment